(A) Shown is a schematic of the experimental strategy for the generation of the bigenic CamKIIα-tTA::TetO-hM3Dq mouse line to selectively drive the expression of the hM3Dq DREADD in CamKIIα-positive …
(A) Shown is a schematic of the experimental strategy for the generation of the bigenic CamKIIα-tTA::TetO-hM3Dq mouse line to selectively drive the expression of the HA-tagged hM3Dq DREADD in …
(A) Experimental paradigm to assess the influence of chronic PNCNO-mediated hM3Dq DREADD activation of CamKIIα-positive forebrain excitatory neurons on p-ERK/ERK expression. CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is the experimental paradigm to assess the effects of chronic CNO-mediated hM3Dq DREADD activation of CamKIIα-positive forebrain excitatory neurons using whole-cell patch clamp. CamKIIα-tTA…
(A) Shown is an experimental paradigm to assess the effects of chronic CNO-mediated hM3Dq DREADD activation of CamKIIα-positive forebrain excitatory neurons using whole-cell patch clamp. CamKIIα-tTA:…
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
Source data for Figure 2.
(A) Shown is a schematic of the experimental paradigm used to determine the influence of chronic CNO-mediated hM3Dq DREADD activation of CamKIIα-positive forebrain excitatory neurons in …
(A) Shown is a schematic of the experimental paradigm used to determine the influence of chronic CNO-mediated hM3Dq DREADD activation of CamKIIα-positive forebrain excitatory neurons in …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to assess the influence of chronic CNO administration in genotype-control mice. Mouse pups, single-positive for either CamKIIα-tTA or TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to assess the influence of chronic CNO administration in the background strain for the bigenic CamKIIα-tTA::TetO-hM3Dq, namely the C57BL/6J …
(A) Shown is a schematic of the experimental paradigm to induce chronic C21-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
Source data for Figure 3.
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
Metabolism of [1,6-13C2]glucose in glutamatergic and GABAergic neurons produces GluC4, which is then decarboxylated to GABAC2 by GAD enzyme in GABAergic neurons. The glutamate–glutamine and …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
List of qPCR primers.
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
(A) Shown is a schematic of the experimental paradigm to induce chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons using bigenic CamKIIα-tTA::TetO-hM3Dq …
Postnatal Day 7 | CA1 pyramidal neurons | |||||
---|---|---|---|---|---|---|
Intrinsic Properties | ||||||
Group | RMP (mV) | Input resistance (MΩ) | τ (ms) | Sag (mV) | Sag (%) | Accomodation index |
Vehicle | −55.96 ± 1.923 | 310.2 ± 39.43 | 34.77 ± 4.62 | −10.09 ± 2.65 | 10.15 ± 2.42 | 0.32 ± 0.06 |
PNCNO | −51.66 ± 1.151$ | 352.3 ± 35.23 | 33.62 ± 3.65 | −8.99 ± 1.66 | 9.10 ± 1.22 | 0.48 ± 0.09 |
CamKIIα-tTA::TetO-hM3Dq bigenic mouse pups were fed either CNO (1 mg/kg) or vehicle from P2 to P7, and whole-cell patch clamp was performed at P7 to determine intrinsic membrane properties. No significant effect was noted for input resistance, membrane time constant (τ), sag voltage, percent sag and accommodation index across treatment groups. We noted a trend toward an increase in resting membrane potential (RMP) in hippocampi derived from the PNCNO-treated mouse pups as compared to vehicle-treated controls. $p=0.06 as compared to vehicle-treated controls (n = 6 cells for vehicle; n = 9 cells for PNCNO) using the two-tailed, unpaired Student’s t-test.
[1,6-13C]glucose Infusion | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Concentration of brain metabolites determined relative to [2-13C]glycine (µmol/g) | ||||||||||||
Brain Region | Group | Glu | GABA | Gln | Asp | NAA | Ala | Lac | Ino | Tau | Cho | Cre |
Hippocampus | Vehicle | 13.5 ± 0.3 | 3.6 ± 0.2 | 5.0 ± 0.1 | 2.3 ± 0.1 | 8.9 ± 0.1 | 0.7 ± 0.1 | 3.0 ± 0.6 | 7.3 ± 0.2 | 8.6 ± 0.2 | 2.3 ± 0.1 | 13.5 ± 0.2 |
PNCNO | 13.7 ± 0.3 | 3.7 ± 0.2 | 4.8 ± 0.1 | 2.5 ± 0.1 | 9.0 ± 0.1 | 0.6 ± 0.1* | 2.3 ± 0.2 | 7.5 ± 0.2 | 8.5 ± 0.2 | 2.3 ± 0.1 | 13.5 ± 0.3 | |
Cortex | Vehicle | 13.5 ± 0.3 | 3.4 ± 0.1 | 4.7 ± 0.1 | 2.9 ± 0.1 | 9.5 ± 0.4 | 0.7 ± 0.1 | 7.0 ± 1.3 | 6.0 ± 0.2 | 9.1 ± 0.1 | 2.0 ± 0.1 | 12.9 ± 0.1 |
PNCNO | 14.0 ± 0.2 | 3.3 ± 0.1 | 4.5 ± 0.1 | 3.2 ± 0.1$ | 9.6 ± 0.4 | 0.6 ± 0.1 | 5.3 ± 0.5 | 6.0 ± 0.1 | 9.1 ± 0.2 | 2.1 ± 0.1 | 12.9 ± 0.2 |
Chronic CNO-mediated hM3Dq DREADD activation in CamKIIα-positive forebrain excitatory neurons was achieved using bigenic CamKIIα-tTA::TetO-hM3Dq mouse pups that were fed CNO (PNCNO; 1 mg/kg) or vehicle from P2 to P14 and then left undisturbed for 3 months prior to metabolic analysis performed in adulthood on male mice and NMR spectroscopy on the hippocampus and cortex was performed to acquire 1H-[12C + 13C] spectra. The concentration of metabolites was determined relative to [2-13C]glycine. Glu: Glutamate; GABA: γ-aminobutyric acid; Gln: Glutamine; Asp: Aspartate; NAA: N-acetylaspartate; Suc: Succinate; Ala: Alanine; Lac: Lactose; Ino; Inositol; Tau: Taurine; Cho: Choline; Cre: Creatine. Results are expressed as the mean ± S.E.M (n = 7 per group). *p<0.05, $p=0.06; as compared to vehicle-treated controls using the two-tailed, unpaired Student’s t-test.
Adults | CA1 pyramidal neurons | |||||
---|---|---|---|---|---|---|
Intrinsic properties | ||||||
Group | RMP (mV) | Input resistance (MΩ) | τ (ms) | Sag (mV) | Sag (%) | Accomodation index |
Vehicle | −62.3 ± 0.655 | 195.1 ± 10.89 | 18.87 ± 1.574 | −4.282 ± 0.288 | 4.956 ± 0.317 | 0.375 ± 0.054 |
PNCNO | −62.81 ± 0.682 | 180.2 ± 10.46 | 18.66 ± 1.269 | −3.603 ± 0.397 | 4.173 ± 0.420 | 0.392 ± 0.046 |
Chronic CNO-mediated hM3Dq DREADD activation of CamKIIα-positive forebrain excitatory neurons was performed using bigenic CamKIIα-tTA::TetO-hM3Dq mouse pups that were fed CNO (PNCNO; 1 mg/kg) or vehicle from P2 to P14 and then left undisturbed for 3 months prior to electrophysiological analysis, in acute hippocampal slices derived from adult male mice. Whole-cell patch clamp was performed to determine intrinsic properties in the somata of CA1 pyramidal neurons. RMP: Resting membrane potential, τ: Membrane time constant. Results are expressed as the mean ± S.E.M. (n = 18 cells for vehicle; n = 25 cells for PNCNO).
Summary of statistical analysis.